Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Sends Letter to FDA on Drug Shortages

Wednesday, June 08, 2011

As a follow up to a meeting with the Food and Drug Administration (FDA) in late May, ASA sent a letter to the FDA that discusses the extent of anesthesia drug shortages and offers some recommendations on actions the FDA can take to help reduce drug shortages. In the letter, authored by ASA Vice President of Scientific Affairs Arnold J. Berry, M.D., ASA reports the results of the recent drug shortage survey of ASA members. In that survey, 90.4% of respondents reported they were currently experiencing an anesthesia drug shortage and 98.1% of respondents reported experiencing a shortage of at least one anesthesia drug in the last year. 
 
ASA recommends in the letter that the FDA pursue six different actions that could help alleviate drug shortages.

The FDA has agreed to host a hearing on drug shortages after Senator Blumenthal sent a letter requesting an FDA hearing. The Government Accountability Office (GAO) has also agreed to start an investigation into drug shortages at the urging of Senators Blumenthal, Casey and Harkin.

ASA is continuing to work with all stakeholders to alleviate drug shortages.

Click here to read the letter ASA sent to the FDA.

Click here for more information on drug shortages.

 

« Back to Washington Alerts